{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:13:00Z","timestamp":1757700780279},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5722,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Dermatology"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1046\/j.1365-2133.2000.03263.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:23:02Z","timestamp":1047360182000},"page":"171-176","source":"Crossref","is-referenced-by-count":20,"title":["Successful treatment of aphthous ulcerations in AIDS patients using topical granulocyte-macrophage colony-stimulating factor"],"prefix":"10.1093","volume":"142","author":[{"given":"P.","family":"Herranz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0733-8635(18)30399-1","article-title":"Oral manifestations of HIV infection.","volume":"9","author":"Greenspan","year":"1991","journal-title":"Dermatol Clin"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0030-4220(92)90122-7","article-title":"Recurrent aphthous ulcers in association with HIV infection: diagnosis and treatment.","volume":"73","author":"MacPhail","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0030-4220(91)90524-G","article-title":"Major aphthous-like ulcers in patients with AIDS.","volume":"71","author":"Phelan","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0190-9622(93)70222-F","article-title":"An evaluation of oral ulcers in patients with AIDS and AIDS-related complex.","volume":"29","author":"Liang","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0030-4220(92)90196-W","article-title":"Oral ulceration and iatrogenic disease in HIV infection.","volume":"73","author":"Reichart","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB6|cit6","first-page":"313","article-title":"Detection of human immunodeficiency virus-1 by 35S-RNA in situ hybridization in solitary esophageal ulcers in two patients with the acquired immune deficiency syndrome.","volume":"84","author":"Kotler","year":"1989","journal-title":"Am J Gastroentereol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-110-11-937","article-title":"Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS).","volume":"110","author":"Gill","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199705223362103","article-title":"Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus.","volume":"336","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/clinids\/12.1.41","article-title":"Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness.","volume":"12","author":"Ruef","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02990841","article-title":"Granulocyte-macrophage colony-stimulating factor and the immune system.","volume":"13","author":"Tarr","year":"1996","journal-title":"Med Oncol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00062752-199704030-00008","article-title":"Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection.","volume":"4","author":"Frumkin","year":"1997","journal-title":"Curr Opin Hematol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin\u2019s lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB13|cit13","first-page":"278","article-title":"AIDS Clinical Trials Group Study 094: a phase I\/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi\u2019s sarcoma.","volume":"3","author":"Gill","year":"1997","journal-title":"Cancer J Sci Am"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1258\/0956462971920226","article-title":"Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in the treatment of paediatric AIDS-related cryptococcosis.","volume":"8","author":"Manfredi","year":"1997","journal-title":"Int J STD AIDS"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1179\/joc.1996.8.3.214","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in leukopenic patients with advanced HIV disease.","volume":"8","author":"Manfredi","year":"1996","journal-title":"J Chemother"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB16|cit16","first-page":"149","article-title":"New clinical applications of granulocyte-macrophage colony-stimulating factor.","volume":"13","author":"Masucci","year":"1996","journal-title":"Med Oncol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1084\/jem.175.6.1717","article-title":"Novel responses of human skin to intradermal recombinant granulocyte\/macrophage colony stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.","volume":"175","author":"Kaplan","year":"1992","journal-title":"J Exp Med"},{"issue":"Suppl. 1","key":"10.1046\/j.1365-2133.2000.03263.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/stem.5530120719","article-title":"Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).","volume":"12","author":"Jones","year":"1994","journal-title":"Stem Cells (Dayt)"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/archsurg.1991.01410250080013","article-title":"Effects of granulocyte-macrophage colony-stimulating factor in burn patients.","volume":"1261","author":"Cioffi","year":"1991","journal-title":"Arch Surg"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB20|cit20","first-page":"325","article-title":"Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing.","volume":"115","author":"Jyung","year":"1994","journal-title":"Surgery"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(94)91819-8","article-title":"Quick healing of leg ulcers after molgramostim.","volume":"344","author":"Da Costa","year":"1994","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1445-5994.1996.tb01936.x","article-title":"Rapid healing of an indolent leg ulcer with topical rhGM-CSF.","volume":"26","author":"Hui","year":"1996","journal-title":"Aust NZJ Med"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0163-4453(97)91809-0","article-title":"Pressure ulcer accelerated healing with local injections of granulocyte macrophage-colony stimulating factor.","volume":"35","author":"El-Saghir","year":"1997","journal-title":"J Infect"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000246583","article-title":"Ulcerated hemangioma successfully treated with interferon alfa-2b and topical granulocyte-macrophage colony-stimulating factor.","volume":"191","author":"Illum","year":"1995","journal-title":"Dermatology"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0140-6736(93)93174-Y","article-title":"Local peri-lesional therapy with rhGM-CSF for Kaposi\u2019s sarcoma.","volume":"341","author":"Boente","year":"1993","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198806023182202","article-title":"Effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium.","volume":"318","author":"Gabrilove","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/1097-0142(19900801)66:3<423::AID-CNCR2820660304>3.0.CO;2-V","article-title":"Mitoxantrone\/high dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin\u2019s lymphoma.","volume":"66","author":"Ho","year":"1990","journal-title":"Cancer"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB28|cit28","first-page":"949","article-title":"Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.","volume":"15","author":"Nemunaitis","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.1995.13.10.2620","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leucovorin chemotherapy.","volume":"13","author":"Chi","year":"1995","journal-title":"J Clin Oncol"},{"issue":"Suppl. 8","key":"10.1046\/j.1365-2133.2000.03263.x-BIB30|cit30","first-page":"1062","article-title":"GM-CSF mouthwashes to attenuate severe mucositis after high dose chemotherapy and allogeneic bone marrow transplantation (BMT), or autologous peripheral blood stem cell transplantation (APBSCT).","volume":"5","author":"Reinoso","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB31|cit31","unstructured":"Ovilla R Rubio ME Borbolla JR. GM-CSF mouthwashes as treatment of oral mucositis after intensive chemotherapy with or without bone marrow transplantation Twentieth Annual European Bone Marrow Transplant Conference, March 13-17 1994 216"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0167-8140(97)01936-1","article-title":"Granulocyte-macrophage colony-stimulating factor mouthwashes improve radiation induced mucositis in AIDS patients.","volume":"43","author":"De la Torre","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archderm.1996.03890350143038","article-title":"Granulocyte colony-stimulating factor treatment of cyclic neutropenia with recurrent oral aphthae.","volume":"132","author":"Fink-Puches","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0190-9622(95)91439-0","article-title":"Thalidomide-resistant HIV-associated aphthae successfully treated with granulocyte colony-stimulating factor.","volume":"33","author":"Manders","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB35|cit35","first-page":"439","article-title":"Oral and esophageal aphthous ulcers in a child with AIDS successfully treated with colony stimulating factors (GM-CSF).","volume":"15","author":"Pocheville","year":"1997","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/1523-1747.ep12396936","article-title":"GM-CSF activates regenerative epidermal growth factor and stimulates keratinocyte proliferation in human skin in vivo.","volume":"103","author":"Braunstein","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1200\/JCO.1996.14.5.1741","article-title":"Role of granulocyte-macrophage colony-stimulating factor in chemoradiotherapy-induced oral mucositis.","volume":"14","author":"Wardley","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0190-9622(96)90439-9","article-title":"A generalized cutaneous reaction induced by granulocyte colony stimulating factor.","volume":"34","author":"Glass","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00000372-199504000-00001","article-title":"Report of three cases of cutaneous reactions to granulocyte macrophage-colony stimulating factor and a review of the literature.","volume":"17","author":"Scott","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archderm.1994.01690010081012","article-title":"Leukocyte colony-stimulating factors: a review of associated neutrophilic dermatoses and vasculitides.","volume":"130","author":"Johnson","year":"1994","journal-title":"Arch Dermatol"},{"issue":"Suppl. 2","key":"10.1046\/j.1365-2133.2000.03263.x-BIB41|cit41","first-page":"S9","article-title":"Haematopoietic growth factors as supportive therapy in HIV-infected patients.","volume":"9","author":"Hermans","year":"1995","journal-title":"AIDS"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jlb.62.1.41","article-title":"GM-CSF and its effects on replication of HIV-1 in cells of macrophage lineage.","volume":"62","author":"Crowe","year":"1997","journal-title":"J Leukoc Biol"},{"key":"10.1046\/j.1365-2133.2000.03263.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0140-6736(96)90324-4","article-title":"GM-CSF increases HIV-1 load.","volume":"347","author":"Lafeuillade","year":"1996","journal-title":"Lancet"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.2000.03263.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:27:48Z","timestamp":1676377668000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/142\/1\/171\/6689720"}},"subtitle":["GM-CSF FOR AIDS APHTHOUS ULCERS"],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03263.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}